Affordable Access

Publisher Website

Alpha-Methyldopa-Induced Autoimmune Hemolytic Anemia in the Third Trimester of Pregnancy

Authors
Journal
Case Reports in Obstetrics and Gynecology
2090-6684
Publisher
Hindawi Publishing Corporation
Publication Date
Volume
2013
Identifiers
DOI: 10.1155/2013/150278
Source
Legacy
Keywords
  • Case Report
Disciplines
  • Medicine

Abstract

Alpha-methyldopa has been demonstrated to be safe for use during pregnancy and is now used to treat gestational hypertension. In pregnancy, alpha-methyldopa-induced autoimmune hemolytic anemia does not have typical features and the severity of symptoms ranges from mild fatigue to dyspnea, respiratory failure, and death if left untreated. A case of alpha-methyldopa-induced autoimmune hemolytic anemia in a 36-year-old gravida 2, para 1 woman at 37+6 weeks of gestation is reported herein along with the differential diagnostic procedure and the potential risks to the mother and the fetus.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments